GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDarktrace Regulatory News (DARK)

Share Price Information for Darktrace (DARK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 579.80
Bid: 579.60
Ask: 579.80
Change: -0.20 (-0.03%)
Spread: 0.20 (0.035%)
Open: 582.00
High: 582.00
Low: 577.20
Prev. Close: 580.00
DARK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - AXA INVESTMENT MANAGERS: Darktrace plc

29 Apr 2024 15:07

Form 8.3 - AXA INVESTMENT MANAGERS: Darktrace plc

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:AXA Investment Managers S.A.
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. 
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeDarktrace plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: 
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure26 April 2024
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”N/A

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:1p ordinary
 InterestsShort positions
 Number%Number%
(1) Relevant securities owned and/or controlled:10,342,2601.47  
(2) Cash-settled derivatives:    
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:    
TOTAL: AXA Investment Managers does not have discretion regarding voting decisions in respect of 18,500 shares that are included in this total.10,342,2601.47  

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists: 
Details, including nature of the rights concerned and relevant percentages: 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
    

(b) Cash-settled derivative transactions

Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
     

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unit
        

(ii) Exercise

Class of relevant securityProduct descriptione.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
     

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable)
    

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure:29 April 2024
Contact name:Sabrina AID
Telephone number*:+33 1 44 45 58 79

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
29th Apr 20241:42 pmEQSForm 8.3 - The Vanguard Group, Inc.: Darktrace plc
29th Apr 20241:35 pmRNSForm 8.3 - Darktrace Plc
29th Apr 20241:23 pmRNSForm 8.5 (EPT/NON-RI) Darktrace Plc
29th Apr 202412:35 pmRNSForm 8.3 - Darktrace plc
29th Apr 202411:30 amRNSForm 8.5 (EPT/RI) - Darktrace
29th Apr 202411:16 amRNSForm 8.5 (EPT/NON-RI)
29th Apr 202410:36 amGNWForm 8.3 - Darktrace Plc
29th Apr 20249:37 amPRNForm 8.3 - Darktrace plc
26th Apr 20248:11 amRNSRecommended Cash Acquisition of Darktrace plc
23rd Apr 20242:09 pmRNSHolding(s) in Company
11th Apr 20247:00 amRNSQ3 FY 2024 Trading Update
9th Apr 20248:00 amRNSNew: The Darktrace ActiveAI Security Platform
3rd Apr 20241:32 pmRNSHolding(s) in Company
26th Mar 20245:32 pmRNSHolding(s) in Company
25th Mar 202411:54 amRNSIssue & Allotment of Shares & Total Voting Rights
22nd Mar 20247:00 amRNSResult of Secondary Placing in Darktrace
21st Mar 20244:42 pmRNSProposed Secondary Placing in Darktrace
21st Mar 20247:00 amRNSDirector/PDMR Shareholding
19th Mar 20244:04 pmRNSDirector/PDMR Shareholding
13th Mar 202410:23 amRNSHolding(s) in Company
11th Mar 202410:42 amRNSHolding(s) in Company
7th Mar 20247:00 amRNSHalf-Year Results
5th Mar 20241:00 pmRNSDarktrace Federal: High "In Process" Designation
5th Mar 20247:00 amRNSDarktrace Appoints Chief People Officer
29th Feb 20244:53 pmRNSTotal Voting Rights
26th Feb 20243:31 pmRNSHolding(s) in Company
31st Jan 20244:45 pmRNSTotal Voting Rights
23rd Jan 20243:04 pmRNSHolding(s) in Company
15th Jan 20241:58 pmRNSDirector/PDMR Shareholding
11th Jan 20247:00 amRNS1H FY 2024 Trading Update
3rd Jan 202411:39 amRNSIssue & Allotment of Shares & Total Voting Rights
2nd Jan 20247:00 amRNSTotal Voting Rights
27th Dec 20234:06 pmRNSHolding(s) in Company
27th Dec 20237:00 amRNSHolding(s) in Company
19th Dec 20235:18 pmRNSDirector/PDMR Shareholding
7th Dec 20232:09 pmRNSResult of AGM
30th Nov 20234:41 pmRNSTotal Voting Rights
29th Nov 20234:18 pmRNSDirector/PDMR Shareholding
22nd Nov 20239:13 amRNSAppointment of Independent Non-Executive Directors
20th Nov 20232:53 pmRNSHolding(s) in Company
7th Nov 20235:57 pmRNSNotice of AGM
7th Nov 20237:00 amRNSDarktrace Hosts Inaugural Technology Day
1st Nov 20237:00 amRNSEBT Market Purchase Programme
1st Nov 20237:00 amRNSTransaction in Own Shares
31st Oct 20235:08 pmRNSTotal Voting Rights
31st Oct 20237:00 amRNSTransaction in Own Shares
30th Oct 20237:00 amRNSTransaction in Own Shares
27th Oct 20237:00 amRNSTransaction in Own Shares
26th Oct 20237:00 amRNSDarktrace Unveils New Cloud Security Solution
26th Oct 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.